FDA Inspection 1227720 — Ionetix

Ionetix — FEI 3016460801

The FDA completed an inspection of Ionetix on Jan 19, 2024 in Pittsburgh, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 19, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pittsburgh, PA (United States)

Citations

IDCFRDescription
1775321 CFR 212.30(c)Contact surfaces

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.